{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:35:25Z","timestamp":1757608525488,"version":"3.44.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04445-0","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T16:10:17Z","timestamp":1756829417000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a nomogram for predicting hyperphosphatemia in non-dialysis patients with chronic kidney disease"],"prefix":"10.1186","volume":"26","author":[{"given":"Xianhui","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caiyun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qitong","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongli","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiqin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenghua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaochun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"4445_CR1","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2019.14745","volume":"322","author":"TK Chen","year":"2019","unstructured":"Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019;322:1294\u2013304. https:\/\/doi.org\/10.1001\/jama.2019.14745.","journal-title":"JAMA"},{"key":"4445_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration. Global, regional, and National burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395:709\u201333. https:\/\/doi.org\/10.1016\/S0140-6736(20)30045-3.","journal-title":"Lancet"},{"key":"4445_CR3","doi-asserted-by":"publisher","first-page":"10881100","DOI":"10.2215\/CJN.11901115","volume":"11","author":"CS Ritter","year":"2016","unstructured":"Ritter CS, Slatopolsky E. Phosphate toxicity in CKD: the killer among Us. Clin J Am Soc Nephrol. 2016;11:10881100. https:\/\/doi.org\/10.2215\/CJN.11901115.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4445_CR4","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1053\/j.ajkd.2011.07.020","volume":"58","author":"J Kendrick","year":"2011","unstructured":"Kendrick J, Chonchol M. The role of phosphorus in the development and progression of vascular calcification. Am J Kidney Dis. 2011;58:826\u201334. https:\/\/doi.org\/10.1053\/j.ajkd.2011.07.020.","journal-title":"Am J Kidney Dis"},{"key":"4445_CR5","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1681\/ASN.2004070602","volume":"16","author":"B Kestenbaum","year":"2005","unstructured":"Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol. 2005;16:520\u20138. https:\/\/doi.org\/10.1681\/ASN.2004070602.","journal-title":"J Am Soc Nephrol"},{"key":"4445_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.15537\/smj.2015.1.9843","volume":"36","author":"MA Akram","year":"2015","unstructured":"Akram MA, Hyperphosphatemia. The hidden killer in chronic kidney disease. Saudi Med J. 2015;36:13\u20139. https:\/\/doi.org\/10.15537\/smj.2015.1.9843.","journal-title":"Saudi Med J"},{"key":"4445_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2369-14-153","volume":"14","author":"A Covic","year":"2013","unstructured":"Covic A, Rastogi A. Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence. BMC Nephrol. 2013;14:153. https:\/\/doi.org\/10.1186\/1471-2369-14-153.","journal-title":"BMC Nephrol"},{"issue":"Suppl 1","key":"4445_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10157-016-1359-4","volume":"21","author":"I Kaneko","year":"2017","unstructured":"Kaneko I, Tatsumi S, Segawa H, Miyamoto KI. Control of phosphate balance by the kidney and intestine. Clin Exp Nephrol. 2017;21(Suppl 1):21\u20136. https:\/\/doi.org\/10.1007\/s10157-016-1359-4.","journal-title":"Clin Exp Nephrol"},{"key":"4445_CR9","doi-asserted-by":"publisher","first-page":"S1617","DOI":"10.1016\/S1769-7255(18)30647-3","volume":"14","author":"T Hannedouche","year":"2018","unstructured":"Hannedouche T, Fouque D, Joly D. Metabolic complications in chronic kidney disease: hyperphosphatemia, hyperkalemia and anemia. Nephrol Ther. 2018;14:S1617\u201325. https:\/\/doi.org\/10.1016\/S1769-7255(18)30647-3.","journal-title":"Nephrol Ther"},{"key":"4445_CR10","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s40620-016-0306-5","volume":"29","author":"A Cupisti","year":"2016","unstructured":"Cupisti A, Moriconi D, D\u2019Alessandro C, Verde F, Marchini M, Saba A, Egidi MF. The extra-phosphate intestinal load from medications: is it a real concern? J Nephrol. 2016;29:857\u201362. https:\/\/doi.org\/10.1007\/s40620-016-0306-5.","journal-title":"J Nephrol"},{"key":"4445_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group","year":"2017","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).\u2002Kidney. Int Suppl. 2017;7:1\u201359. https:\/\/doi.org\/10.1016\/j.kisu.2017.04.001.","journal-title":"Int Suppl"},{"key":"4445_CR12","doi-asserted-by":"publisher","first-page":"1607000","DOI":"10.3389\/ijph.2024.1607000","volume":"69","author":"W Jie","year":"2024","unstructured":"Jie W, Yao M, Wang M, Wang Y, Jia Y, Liu Y, Zou K, Sun X. Analysis of the economic burden of chronic kidney disease with comorbidities among patients in xuzhou, China. Int J Public Health. 2024;69:1607000. https:\/\/doi.org\/10.3389\/ijph.2024.1607000.","journal-title":"Int J Public Health"},{"key":"4445_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"Kidney Disease","year":"2013","unstructured":"Kidney Disease. Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1\u2013150.","journal-title":"Kidney Int Suppl"},{"key":"4445_CR14","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1053\/j.ajkd.2017.07.019","volume":"70","author":"T Isakova","year":"2017","unstructured":"Isakova T, Nickolas TL, Denburg M, Yarlagadda S, Weiner DE, Guti\u00e9rrez OM, Bansal V, Rosas SE, Nigwekar S, Yee J, Kramer H. KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney Disease-Mineral and bone disorder (CKD-MBD). Am J Kidney Dis. 2017;70:737\u201351. https:\/\/doi.org\/10.1053\/j.ajkd.2017.07.019.","journal-title":"Am J Kidney Dis"},{"key":"4445_CR15","volume-title":"The elements of statistical learning: data mining, inference, and prediction","author":"T Hastie","year":"2008","unstructured":"Hastie T, Tibshirani R, Friedman J. The elements of statistical learning: data mining, inference, and prediction. 2nd ed. New York: Springer; 2008.","edition":"2"},{"key":"4445_CR16","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.3390\/nu13051670","volume":"13","author":"K Tsuchiya","year":"2021","unstructured":"Tsuchiya K, Akihisa T. The importance of phosphate control in chronic kidney disease. Nutrients. 2021;13:1670. https:\/\/doi.org\/10.3390\/nu13051670.","journal-title":"Nutrients"},{"key":"4445_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1055\/s-0041-1732495","volume":"14","author":"DD Patel","year":"2021","unstructured":"Patel DD, Vachhani U, Rajput A, Raghavani P, Parchwani DN, Dholariya S. Analysis of the prevalence and severity of dysregulated bone mineral homeostasis in nondialyzed chronic kidney disease patients. J Lab Physicians. 2021;14:144\u201350. https:\/\/doi.org\/10.1055\/s-0041-1732495.","journal-title":"J Lab Physicians"},{"key":"4445_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/nu9020152","volume":"9","author":"R Imtiaz","year":"2017","unstructured":"Imtiaz R, Hawken S, McCormick BB, Leung S, Hiremath S, Zimmerman DL. Diabetes mellitus and younger age are risk factors for hyperphosphatemia in peritoneal Dialysis patients. Nutrients. 2017;9:152. https:\/\/doi.org\/10.3390\/nu9020152.","journal-title":"Nutrients"},{"key":"4445_CR19","doi-asserted-by":"publisher","first-page":"1217890","DOI":"10.3389\/fmed.2023.1217890","volume":"10","author":"X Yin","year":"2023","unstructured":"Yin X, Zhang F, Shi Y. Prevalence and factors associated with hyperphosphatemia in continuous ambulatory peritoneal Dialysis patients: a cross-sectional study. Front Med (Lausanne). 2023;10:1217890. https:\/\/doi.org\/10.3389\/fmed.2023.1217890.","journal-title":"Front Med (Lausanne)"},{"key":"4445_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12882-022-02918-0","volume":"23","author":"J Jung","year":"2022","unstructured":"Jung J, Jeon-Slaughter H, Nguyen H, Patel J, Sambandam KK, Shastri S, Van Buren PN. Hyperphosphatemia and its relationship with blood pressure, vasoconstriction, and endothelial cell dysfunction in hypertensive Hemodialysis patients. BMC Nephrol. 2022;23:291. https:\/\/doi.org\/10.1186\/s12882-022-02918-0.","journal-title":"BMC Nephrol"},{"key":"4445_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.22159\/ijpps.2017v9i12.22425","volume":"9","author":"SA Rabbani","year":"2017","unstructured":"Rabbani SA, BS S, Rao PGM, Kurian MT, Essawy BE. Hyperphosphatemia in end stage renal disease: prevalence and patients characteristics of multiethnic population of united Arab Emirates. Int J Pharm Pharm Sci. 2017;9:283\u20137. https:\/\/doi.org\/10.22159\/ijpps.2017v9i12.22425.","journal-title":"Int J Pharm Pharm Sci"},{"key":"4445_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1681\/asn.2008020159","volume":"20","author":"O Moranne","year":"2009","unstructured":"Moranne O, Froissart M, Rossert J, Gauci C, Boffa JJ, Haymann JP, et al. Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol. 2009;20:164\u201371. https:\/\/doi.org\/10.1681\/asn.2008020159.","journal-title":"J Am Soc Nephrol"},{"key":"4445_CR23","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1093\/ndt\/gfq808","volume":"26","author":"CM O\u2019Seaghdha","year":"2011","unstructured":"O\u2019Seaghdha CM, Hwang SJ, Muntner P, Melamed ML, Fox CS. Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease. Nephrol Dial Transpl. 2011;26:2885\u201390. https:\/\/doi.org\/10.1093\/ndt\/gfq808.","journal-title":"Nephrol Dial Transpl"},{"key":"4445_CR24","doi-asserted-by":"publisher","unstructured":"Pavan Kumar M. Clinico-pathological correlation study in chronic kidney disease patients undergoing hemodialysis. Indian J Pathol Oncol. 2023;10:141-7. https:\/\/doi.org\/10.18231\/j.ijpo.2023.030.","DOI":"10.18231\/j.ijpo.2023.030"},{"key":"4445_CR25","doi-asserted-by":"publisher","unstructured":"Carullo N, Sorbo D, Faga T, Pugliese S, Zicarelli MT, Costa D et al. Anemia and mineral bone disorder in kidney disease patients. The role of FGF-23 and other related factors. Int J Mol Sci. 2024;25:12838. https:\/\/doi.org\/10.3390\/ijms252312838.","DOI":"10.3390\/ijms252312838"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04445-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04445-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04445-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T05:02:26Z","timestamp":1756875746000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04445-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4445"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04445-0","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Nanping First Hospital affiliated to Fujian Medical University (approval number: NPSY202401007). Owing to the retrospective nature of the study, the requirement for written informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"512"}}